Exploring the mechanism of YangXue QingNao Wan based on network pharmacology in the treatment of Alzheimer’s disease
It is clinical reported that YangXue QingNao Wan (YXQNW) combined with donepezil can significantly improve the cognitive function of AD patients. However, the mechanism is not clear. A network pharmacology approach was employed to predict the protein targets and affected pathways of YXQNW in the tre...
Main Authors: | Yuying Zhang, Kaimin Guo, Pengfei Zhang, Mengying Zhang, Xiaoqiang Li, Shuiping Zhou, He Sun, Wenjia Wang, Hui Wang, Yunhui Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.942203/full |
Similar Items
-
YangXue QingNao Wan and Silibinin Capsules, the Two Chinese Medicines, Attenuate Cognitive Impairment in Aged LDLR (+/-) Golden Syrian Hamsters Involving Protection of Blood Brain Barrier
by: You-Yu Gu, et al.
Published: (2018-06-01) -
A meta‐analysis of the effectiveness of Yangxue Qingnao granules for the treatment of chronic cerebral circulation insufficiency
by: Yujuan Jia, et al.
Published: (2020-05-01) -
YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
by: Xiaowan Wang, et al.
Published: (2017-05-01) -
Protective effects of Qing-Re-Huo-Xue formula on bleomycin-induced pulmonary fibrosis through the p53/IGFBP3 pathway
by: Fangyong Yang, et al.
Published: (2023-03-01) -
YangXue QingNao Wan, a Compound Chinese Medicine, Attenuates Cerebrovascular Hyperpermeability and Neuron Injury in Spontaneously Hypertensive Rat: Effect and Mechanism
by: Ying-Qian Jiao, et al.
Published: (2019-10-01)